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Replication factor 1Replication protein A-1 (RPA-1) is a single-stranded DNA-binding protein involved in DNA metabo-
lism. We previously demonstrated the interaction between LaRPA-1 and telomeric DNA. Here, we
expressed and puriﬁed truncated mutants of LaRPA-1 and used circular dichroism measurements
and molecular dynamics simulations to demonstrate that the tertiary structure of LaRPA-1 differs
from human and yeast RPA-1. LaRPA-1 interacts with telomeric ssDNA via its N-terminal OB-fold
domain, whereas RPA from higher eukaryotes show different binding modes to ssDNA. Our results
show that LaRPA-1 is evolutionary distinct from other RPA-1 proteins and can potentially be used
for targeting trypanosomatid telomeres.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction yeasts and ciliates [4–7]. In trypanosomatids, in spite of the pres-Leishmaniasis is an emerging human disease, which is caused
by a trypanosomatid parasite belonging to the Leishmania genus.
This disease is endemic in many countries, and there are no efﬁ-
cient methods for its control or eradication [1]. Currently, telo-
meres have been considered good targets for the development of
new therapies due to their role in the maintenance of genome sta-
bility [2]. Telomeres are the protective DNA–protein complexes
found at the ends of eukaryotic chromosomes [3]. Telomeric pro-
teins have been found in many organisms, such as vertebrates,ence of LaRbp38, only the orthologs of TRF and Rap-1 reported in
other eukaryotes were found to interact with parasite double-
stranded telomeres [8–11], and very few typical 30 G-overhang
binding proteins have been reported in these protozoa [12–14].
Some of them, including LaRPA-1 [13,14], were isolated in
Leishmania amazonensis telomerase-positive nuclear extracts using
afﬁnity chromatography on the telomeric G-rich strand DNA.
Recently, a trimeric RPA-like complex, which binds speciﬁcally to
telomeric DNA, was described as a component of the telomerase
holoenzyme of the ciliated protozoa Tetrahymena thermophila
[15]. However, in Leishmania and in contrast to expectations, afﬁn-
ity puriﬁed LaRPA-1 was not co-puriﬁed with the other two sub-
units of the canonical RPA heterotrimeric complex [13].
In budding yeast and higher eukaryotes, RF-A (replication factor
A) or RPA respectively, is the main single-stranded DNA-binding
protein that plays multiple roles in DNA processing pathways,
and it is composed of the subunits RPA-1 (also named RPA70 or
Rfa1), RPA-2 (also named RPA32 or Rfa2) and RPA-3 (also named
RPA14 or Rfa3) [16,17]. RPA-1 and RPA-2 interact with
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binding)-fold domains named DNA binding domains A-D in order
of decreasing afﬁnity for ssDNA (single-stranded DNA); DBD A-C
are in RPA-1 and DBD D is in RPA-2 [18–21]. Furthermore, in con-
trast to LaRPA-1, the RPAs from higher eukaryotes bind to ssDNA
through at least three different modes depending on the length
of the ssDNA and the number of ssDNA-binding domains involved
[18].
In this manuscript, we have expressed and puriﬁed three trun-
cated mutants of LaRPA-1 to better understand its telomere inter-
actions. Here, we conﬁrmed that LaRPA-1 interacts with G-rich
single-stranded telomeric DNA using only its N-terminal OBF1
domain. We also created in silico structural models to show rele-
vant structural differences in the LaRPA-1 tertiary structure com-
pared with that of human and yeast RPA-1/Rfa1 and to explain
the LaRPA-1:telomeric DNA interaction at the molecular level.
2. Materials and methods
2.1. Bacterial strain and plasmid vector
The pET-28a+ vector was used to clone the truncated mutants:
LaRPA-1DC-term containing OBF1 and OBF2, both located at the
N-terminal of LaRPA-1; LaRPA-1DOB1,2 containing OBF3 located at
the C-terminal of LaRPA-1 and LaRPA-1DOB1, which lacks the
canonical OBF1 domain. The cloning strategy was based on PCR
and was designed to generate recombinant proteins with an N-ter-
minal 6His-tag. The constructs were used to transform the
Escherichia coli BL21-CodonPlus (DE3)-RP cells (Stratagene).
2.2. Protein expression, puriﬁcation and refolding
To produce the recombinant proteins, E. coli was transformed
using each recombinant plasmid. For expression assays, the trans-
formants were then cultivated in LB medium supplemented with
50 lg of kanamycin/ml and 50 lg of chloramphenicol/ml at 37 C
for 2 h. Protein expression was induced using 1 mM isopropyl
thio-b-D-galactopyranoside (IPTG) at 37 C for an additional 3 h.
Cells were harvested at 4 C, and pellets were suspended in lysis
buffer (50 mM Tris–HCl pH 8.0, 50 mM NaCl, 10 mM EDTA pH
8.0 and 1X protease inhibitor cocktail), disrupted by sonication
and incubated with 5U DNAse I, followed centrifugation at 4 C.
The ﬁnal pellet was suspended in 50 mM glycine pH 8.0 containing
7 M urea, in the presence of 1X protease inhibitor cocktail (Sigma)
and the suspension was loaded in a HiTrapChelating (GE Health-
care) column previously equilibrated with starting buffer (20 mM
Tris HCl pH 7.0, 0.5 M NaCl, 7 M urea, 71 ll/L b-mercaptoethanol).
Proteins were eluted using a linear gradient of 25–500 mM imidaz-
ole in elution buffer (20 mM Tris HCl pH 7.0, 0.5 M NaCl, 7 M urea
and 500 mM imidazole) and an FPLC (AKTAprimeplus). Fractions
containing the recombinant proteins were separated in 12%
SDS–PAGE, pooled and renatured by dialysis in 10 volumes of rena-
turing buffer (20 mM Tris HCl pH 7.0 and 20 mM NaCl) at 4 C.
Heparin (50 lg/ml) was added to each protein suspension before
dialysis to prevent precipitation (see Lira et al. [9] for details).
The protein concentration was determined spectrophotometrically
in a Jasco V530 series spectrophotometer (Jasco, Japan) using the
extinction coefﬁcient of the denatured protein. The purity of the
proteins was conﬁrmed by measuring A280 nm/A260 nm and
using SDS–PAGE.
2.3. Western blotting
The recombinant proteins (0.5 lg each) and proteins obtained
from L. amazonensis nuclear extract [22] were separated using10% SDS–PAGE and subjected to Western blot analysis with anti-
LaRPA-1 according to Siqueira-Neto et al. [14]; the blots were
developed with an alkaline phosphatase-conjugated goat anti-rab-
bit IgG antibody (Bio-Rad) using an Ampliﬁed Alkaline Phospha-
tase Immun-Blot Assay Kit (Bio-Rad) according to the
manufacturer’s instructions (Millipore).
2.4. Circular dichroism spectroscopy
CD measurements were obtained over the spectral ranges of
195–260 nm (for LaRPA-1DOBF1), 197–260 nm (for LaRPA-1DCter)
and 200–260 nm (for LaRPA-1DOBF1,2) using a JASCO J-815 spectro-
polarimeter (JASCO Spectroscopic Co., Ltd., Japan) equipped with a
Peltier thermo-controller. The experiments were performed at
293 K using an optical path length of 0.5 nm, a scanning speed of
100 nm/min, a response time of 1 s, a bandwidth of 2 nm and a
data pitch of 0.5 nm. Twenty spectra were acquired, averaged
and corrected for the buffer solution (baseline) in the presence
and absence of Tel1 and then normalized to the residual molar
ellipticity [h]. The CD spectra of both buffer and Tel1 gave
negligible signals on the concentrations tested. All LaRPA-1
mutants were analyzed in buffer containing 20 mM Tris HCl and
20 mM NaCl, and the effect of telomeric DNA was evaluated by
the addition of 150 pmol of Tel1 (TTAGGG)3 to the protein samples.
Deconvolution of the CD spectra was performed using the
Dichroweb online server [23] with the CDSSTR algorithm and
reference set 4 [24].
2.5. LaRPA-1 and yeast Rfa1 modeling and molecular dynamics (MD)
simulations
Extensive linkers with several very ﬂexible residues connect
OBF2 and OBF3 in LaRPA-1 and DBD-B and DBD-C in the yeast
Rfa1. In both cases, the linkers do not show homologywith any pro-
teinDNA-binding structure; therefore,we created separatedmodels
for the LaRPA-1DCter and LaRPA-1DOBF1,2 truncated mutants and for
Rfa1DBD-A/DBD-B andRfa1DBD-C (GenBankAcc. number P22336). Chain
A (PDB ID 1JMC) of human RPA70 (hRPA70) was selected as the best
template for initial in silico models of LaRPA-1DCter (Score 380.51;
E-value: 3e-57; Identity: 40%) and Rfa1DBD-A/DBD-B (Score: 373.7;
E-value: 5.4e-60; Identity: 42%). Chain C (PDB ID 1L1O) of human
RPA70 (hRPA70)was selected as the best template for initial in silico
models of, LaRPA-1DOBF1,2 (Score 309.71; E-value: 3.4e-48; Identity:
30%) and Rfa1DBD-C (Score: 328.71; E-value: 2.2e-53; Identity: 36%).
The best templateswere chosen according to data obtained from the
proﬁle-based threading method program HHPred [25]. Initial in sil-
icomodelsweregeneratedusing theprogramMODELLERv.9.10 [26]
and the selected templates without a DNA molecule, in the case of
the1JMC-basedmodel. Subsequently, these initialmodelswere sub-
jected to molecular dynamics (MD) simulations executed by GRO-
MACS (Groningen Machine for Chemical Simulation) v.4.5.3 [27] in
the presence of explicit water molecules. The protonation states of
charged groups were set according to pH 7.0. Counter ions were
added to neutralize the system, and theGROMOS96 53a6 force ﬁeld
[28] was chosen to perform the MD simulations. First, 200 ps of MD
simulation with position restraints applied to the protein (PRMD)
was executed to relax the systemgently. Then, 40 ns of unrestrained
MD simulations were performed to evaluate the stability of the
structures.
3. Results and discussion
The search for proteins with homology to the crystallographic
data of RPA-1 from L. amazonensis (LaRPA-1) using the HHPred ser-
ver [25] resulted in sequences containing the DNA-binding
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These DBDs contain OBF domains as protein motifs connected by
two non-folded linkers, and two of them, DBD-A and DBD-B, are
responsible for the interaction of hRPA70 with ssDNA [16,21]. A
fourth OBF domain dubbed RPA70N is also found at the N-terminal
region of hRPA70 from human and other eukaryotes [29,30]. How-
ever, RPA70N instead of binding DNA, it provides the interaction
between hRPA70 and checkpoint proteins [31]. The signiﬁcant
structural similarity between hRPA70 DBDs and LaRPA-1 suggests
that LaRPA-1, in contrast to hRPA70, is formed by three OBF
domains connected by two linkers because LaRPA-1 lacks the
RPA70N OBF domain [14,32].
For detailed analysis to determine which of the three in silico
identiﬁed LaRPA-1 OBF domains are involved in the RPA-telomeric
DNA interaction, we used recombinant proteins comprising
regions of LaRPA-1 that share high structural similarity with
hRPA70; these were three previously constructed truncated
mutants of LaRPA-1 [14]. All three recombinant proteins were
expressed in a bacterial system and puriﬁed using afﬁnity chroma-
tography according to a published protocol standardized for the
puriﬁcation of the full-length LaRPA-1 recombinant protein, with
minor modiﬁcations [9]. The mutant LaRPA-1DOBF1 contains
OBF2, OBF3 and linker 2 but lacks the OBF1 domain, whereas the
mutant LaRPA-1DOBF1,2 contains linker 2 and the C-terminal OBF3
domain, and the mutant LaRPA-1DCter has the ﬁrst two OBF
domains and linker 1, but it lacks the C-terminal OBF3 (Fig. 1A).
As shown in Fig. 1B, all three recombinant proteins were obtained
in highly puriﬁed form and were speciﬁcally recognized by the
anti-LaRPA-1 serum (Fig. 1C, lanes 2–4) [14]. Full-length recombi-
nant LaRPA-1 (with 6His-tag, 53 kDa) and protein extracts
obtained from E. coli BL21 and L. amazonensis nuclear extracts were
used as controls (endogenous LaRPA-1 is 51 kDa) (Fig. 1C, lanes 1, 5
and 6).
Circular dichroism spectra of all puriﬁed LaRPA-1 truncated
mutants (Fig. 1D) showed minimum values that varies from
approximately 206–208 nm, similar to the full length recombinant
LaRPA-1 CD spectra [9], indicating the presence of alpha-helices
and a signiﬁcant percentage of loops and disordered elements in
the LaRPA-1 structure. Indeed, OBF domains also have a signiﬁcant
content of these non-structured elements [33].Fig. 1. Expression, puriﬁcation and secondary structure analysis of LaRPA-1. (A) Diagram
1DOBF1; LaRPA-1DOBF1,2 and LaRPA-1DCter). The numbers above the dark boxes indicate th
PAGE stained with Coomassie blue to show the expression and puriﬁcation of LaRPA-1
Ladder for LaRPA-1DOBF1 and Spectra™Multicolor Broad Range Protein Ladder for LaRPA-1
induced bacterial extract; Lane 4: puriﬁed recombinant deletion mutant. (C) Western blot
Lane 3: puriﬁed LaRPA-1DCter; Lane 4: puriﬁed LaRPA-1DOBF1,2; Lane 5: bacterial extract; L
1 deletion mutants in the absence (black line) or presence (red line) of telomeric DNA (In hRPA70, two non-folded linkers connect DBD-A, DBD-B and
DBD-C (Fig. 2). In the case of LaRPA-1, these linkers are more
extensive due to an insertion of three residues in linker 1, which
is localized between OBF1 and OBF2, and the insertion of seven
residues in linker 2, which is localized between OBF2 and OBF3
(Fig. 2); these insertions most likely contribute to the content of
disordered elements in the LaRPA-1 structure. Deconvolution of
the CD spectra obtained showed (i) 19% alpha helices, 26% beta-
sheet and 55% loops/disordered elements for LaRPA-1DOBF1; (ii)
17% alpha helices, 30% beta-sheet and 53% loops/disordered ele-
ments for LaRPA-1DOBF1,2; and (iii) 17% alpha helices, 29% beta-
sheet and 54% loops/disordered elements for LaRPA-1DCter. These
secondary structure contents are consistent with the OBF domains
that are formed by beta-stranded sheets that coil to form a close
beta-barrel capped by an alpha helix surrounded by several loops
[34,35].
To evaluate the impact of DNA binding on the OBF domains of
the LaRPA-1 structure, CD spectra of all mutants were obtained
in the presence of G-rich single-stranded telomeric DNA (Tel1)
(Fig. 1D). It was previously shown that full-length recombinant
LaRPA-1 and LaRPA-1 from parasite nuclear extracts speciﬁcally
bind G-rich single-stranded telomeric DNA [9,14,32]. Here, we
showed that Tel1 does not produce any modiﬁcation of the CD
spectra of the LaRPA-1DOBF1 and LaRPA-1DOBF1,2 mutants. In con-
trast, Tel1 was able to produce changes in the secondary structure
of LaRPA-1DCter, which contains OBF1 and OBF2 domains. The CD
spectra of LaRPA-1DCter with Tel1 show an enhancement of the
signal from 210 to 230 nm, showing an increase in secondary
structure (Fig. 1D). The deconvolution of the CD spectra of LaR-
PA-1DCter in the presence of Tel1 shows a composition of 19% alpha
helices, 36% beta-sheet and 45% loops/disordered elements. In
comparison with the LaRPA-1DCter spectra without DNA, the spec-
tra for the binding of telomeric DNA showed a decrease in disor-
dered elements (54–45%) and an increase in beta-sheet
secondary structure (29–37%). This increase in secondary structure
in the presence of Tel1 was previously reported for the full-length
recombinant LaRPA-1 [9]. These results are strengthened by EMSA
assays that showed that LaRPA-1 only binds DNA via OBF1 [14].
However, an analysis of the primary sequences of LaRPA-1 and
DBD-A, DBD-B and DBD-C of hRPA70 shows that, despite a fewshowing the structure of recombinant LaRPA-1 and the deletion mutants (LaRPA-
e limits of the three OBF domains in the LaRPA-1 primary sequence. (B) 12% SDS–
deletion mutants. Lane 1: molecular weight maker PageRuler™ Prestained Protein
DOBF1,2 and LaRPA-1DCter; Lane 2: non-induced bacterial extract; Lane 3: 1 mM IPTG-
using anti-LaRPA-1 serum. Lane 1: puriﬁed LaRPA-1; Lane 2: puriﬁed LaRPA-1DOBF1;
ane 6: Leishmania amazonensis extract. (D) Circular dichroism (CD) spectra of LaRPA-
Tel1).
Fig. 2. Amino acid sequence alignments between LaRPA-1 and DNA binding domains (DBD) A, B and C of human RPA70. The regions corresponding to DBD-A, DBD-B, DBD-C
and the zinc ribbon motif of human RPA70, OBF domains 1, 2 and 3 of LaRPA-1, as well as the linkers between the OBF domains, are featured. In addition, the hRPA70 amino
acids involved in DNA binding are highlighted (red rectangles). The residues involved in this function in hRPA70 that are not conserved in LaRPA-1 are marked (\).
Fig. 3. Cartoon representations of the in silico structural models of (A) LaRPA-1DCter and (B) LaRPA-1DOBF1,2 deletion mutants obtained after 40 ns of molecular dynamics (MD)
simulation. Below the structural models, the root mean square deviation (r.m.s.d.) of both models is shown from the MD simulation and GROMACS calculations [27]. All the
MD simulations were performed in a periodic truncated dodecahedron box under constant temperature (298 K) and pressure (1.0 bar). In the LaRPA-1DCter model, the OBF
domains 1 and 2 (OBF1 and OBF2; green and blue, respectively) and the non-folded linker (yellow) between them are visible. In the LaRPA-1DOBF1,2 model, the OBF domain 3
(OBF3; wheat) is visible.
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domains of the hRPA70 structure are conserved in the LaRPA-1
amino acid sequence (Fig. 2). Thus, why is OBF1 the only LaRPA-
1 OBF that is able to bind DNA? To answer this intriguing question,
we constructed in silico models for the LaRPA-1DCter and
LaRPA-1DOBF1,2 mutants.
In silico models for both LaRPA-1 truncated mutants were
obtained after 40 ns of molecular dynamics simulation (MD). In
the LaRPA-1DCter and LaRPA-1DOBF1,2 models (Fig. 3), 95.7% and
96.1%, respectively, of their residues are distributed in favoredand allowed regions of the Ramachandran plot [36], and the mod-
els also show an overall good quality, as evaluated by ProSA-web
[37] (Z-score = 6.49 and 4.94, respectively). These models con-
ﬁrm that LaRPA-1 is formed by three OBF domains linked by two
non-folded linkers that share high structural homology with
DBD-A, DBD-B and DBD-C of hRPA70 (Fig. 3).
The crystal structure of hRPA70 (PDB ID 1JMC) shows a DNA-
binding channel that is extended in approximately a straight line
from DBD-A to DBD-D [35] (Fig. 4A). Despite the structural differ-
ences, in the crystal structure of hRPA70 without DNA (PDB ID
Fig. 4. Cartoon representations of the crystal structures of DBD-A and DBD-B of hRPA70 in the presence of DNA (A) (PDB ID 1JMC) and in the absence of DNA (B) (PDB ID
1FGU) and of the (C) in silico model of the LaRPA-1DCter truncated mutant. The amino acids that stack around DNA in the hRPA70 structure and that were conserved in LaRPA-
1 are represented by sticks. In the crystal structures of DBD-A and DBD-B of hRPA70, the DNA has free access to the DNA-binding channel in both OBF domains. In contrast, in
LaRPA-1, the loops 139–147 and 212–216, analogous to loops 308–316 and 384–388 in hRPA70, enter this binding channel during the molecular dynamics simulation,
blocking the DNA access to OBF2.
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(Fig. 4B). However, in the LaRPA-1DCter model, loops 139–147
and 212–216 enter the DNA-binding channel near the N-terminal
region of OBF2 during the MD simulation, occluding the DNA
access to this domain. These loops correspond to the 308–316
and 384–388 loops of hRPA70, which are exposed to solvent in
both crystal structures; thus, they allow free DNA access to DBD-
A and DBD-B. This difference in tertiary structure between the
hRPA70 crystal structure and the LaRPA-1DCter in silico model can
explain the absence of DNA binding to the OBF2 of LaRPA-1. Fur-
thermore, in hRPA70, the main site of DNA binding is DBD-A,
because this OBF domain binds to ssDNA with higher afﬁnity than
other DNA-binding domains [18,38]. In the case of LaRPA-1, as
demonstrated herein, the access of DNA to OBF2 DNA-binding
channel is blocked by loops 139–147 and 212–216 (Fig. 4C). More-
over, the distance between the OBF1 and OBF2 domains is greater
in LaRPA-1 because linker 1 has an insertion of three amino acids
(Fig. 2). In agreement with these results, when we created an in sil-
ico model for S. cerevisiae Rfa1DBD-A/DBD-B (Suppl. Fig. 1A) we could
observe that the respective loops are also exposed to solvent and
thus, DNA have access to both DBDs. Therefore, this block of DNA
access to OBF2 is probably exclusive to LaRPA-1. Regarding the
absence of DNA binding to OBF3 of LaRPA-1, the amino acids
involved in DNA binding for DBD-C of hRPA70, are also conserved
in OBF3 of LaRPA-1 (Fig. 2). However, the in silico model of
LaRPA-1DOBF1,2 shows that the differences in its tertiary structure
compared with that of hRPA70 DBD-C are even greater than the
differences between OBF1/2 of LaRPA-1 and DBD-A/DBD-B of
hRPA70. In the LaRPA-1DOBF1,2 in silico model, the residues
involved in DNA binding are buried in the inner of the protein,
occluding DNA access to the LaRPA-1 OBF3 binding site (Fig. 5A).
In contrast, in the crystal structure of hRPA70 DBD-C [39], these
residues are exposed to solvent (Fig. 5B). Interestingly, the in silico
model of DBD-C from yeast Rfa1 showed a peculiar feature: theputative residues involved in DNA binding, which are responsible
to stack the DNA on hRPA70 DBD-C crystal structure, are conserved
in yeast Rfa1 but they are neither completely exposed to solvent
like hRPA70 DBD-C, nor completely buried into the inner portion
of the protein, like LaRPA-1 OBF3 (Suppl. Fig. 1B).
Furthermore, hRPA70 DBD-C contains a Cys4-type zinc ribbon
motif formed by three antiparallel b-strands where the ion zinc
is coordinated by four cysteines [39]. Although the functional role
of this motif is poorly understood, in hRPA70, it is involved in DNA
binding because it provides relevant contacts to the phosphodies-
ter backbone, suggesting that any destabilization of the zinc ribbon
motif would lead to a negative impact on DNA binding [39]. The
alignment between LaRPA-1 and hRPA70 shows that the analogous
region of the zinc ribbon motif in LaRPA-1 contains several substi-
tutions, insertions and deletions (Fig. 2), and it is completely disor-
dered (Fig. 5A), most likely contributing to the unsuccessful DNA
binding of LaRPA-1 OBF3. However, four cysteines are conserved
and remain in close contact in the tertiary structure of LaRPA-1
OBF3 (Fig. 5A–B); this ﬁnding suggests that, despite the large dif-
ferences in the primary and secondary structures, LaRPA-1 could
retain the ability to bind zinc, which can be important for other
LaRPA-1 functions. Moreover, analysis of the electrostatic potential
surfaces of the LaRPA-1DOBF1,2 in silico model and DBD-C of hRPA70
in the same orientation after Ca superposition shows relevant dif-
ferences (Fig. 5C and D). A protein face from hRPA70 DBD-C pre-
sents large neutral and slightly charged regions (Fig. 5C),
whereas the analogous face on LaRPA-1 OBF3 is more charged,
and the neutral regions are smaller and more spread along the pro-
tein surface (Fig. 5D). Analysis of the face located 180 in relation to
the previous one in DBD-C showed that a substantial portion of the
surface is formed by positively charged areas that are largely
spread along this protein face, surrounded by some portions of
neutral and negatively charged areas (Fig. 5C). In contrast, on the
analogous face of LaRPA-1 OBF3, the surface is more compact
Fig. 5. Cartoon representations of (A) the in silico model of LaRPA-1DOBF1,2 and (B) the crystal structure of DNA-binding domain C (DBD-C) of hRPA70 (chain C of PDB ID 1L1O).
The residues involved in DNA binding on DBD-C of the hRPA70 structure and those that are conserved on LaRPA-1 are represented by cyan sticks. Although the residues are
exposed to solvent in human RPA70, in the LaRPA-1DOBF1,2 in silico model, these residues are buried in the inner portion of the protein, preventing DNA binding to OBF3 of
LaRPA-1. The zinc ribbon motif present in hRPA70 (three antiparallel b-strands) and its analogous region in LaRPA-1 (disordered region) are highlighted with a special
magniﬁcation of the four cysteines (magenta sticks) that coordinate the zinc ion in the zinc ribbon motif in the DBD. Electrostatic potential surfaces from the crystal structure
of DBD-C of hRPA70 (C) and from the in silico model of LaRPA-1DOBF1,2 (D). Both structures are shown in the same orientation after Ca superposition. The electrostatic
potential surfaces were generated by APBS (Adaptive Poisson–Boltzmann Solver) electrostatics calculations [46], which are available in Chimera v.1.9 [47], after the
transformation from a PDB to a PQR ﬁle using the online server PDB2PQR [48].
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the positively charged area is concentrated at the center of this sur-
face surrounded by neutral regions (Fig. 5D).
Finally, the analysis of the primary structure of the disordered
linkers between the OB fold domains also provided signiﬁcant data.
In comparison with hRPA70, LaRPA-1 has an insertion of three and
seven residues in linkers 1 and 2, respectively.The presence of these residues can promote greater ﬂexibility
between the OBF domains, especially on linker 2, whose insertion
contains three glycines and two alanines. These data suggest a
greater mobility between LaRPA-1 OBF domains compared with
those of hRPA70, which seems to have a more rigid tertiary struc-
ture. In comparison, in yeast Rfa1, the insertion in linker 1 is not
present, but the insertion in linker 2 is composed by eight residues,
Table 1
Different local alignment search tools did not indicate any reliable evidence of a trypanosomatid putative homologue to any of the ciliates, yeast and vertebrates telomeric protein
and genes already known. Local ﬁles from TriTrypDB v7.0 where used as databases on these searches: annotated proteins for blastp, fasta36 and phmmer algorithms and whole
genomes for tblastn and tfastx36 ones.
Query GenBank/PDB IDs Algorithm Top Hits % similarity Align. Length E-value Product description
Mm-Pot1 AAH16121.1 fasta36 LbrM.35.6770 46 164 0.79 Hypothetical protein, conserved
Hs-Pot1 AAH02923.1 fasta36 LtaP32.1860 46 200 0.42 Hypothetical protein, conserved
Hs-CTC1 NP_079375.3 fasta36 LdBPK_070920.1 43 333 0.025 Hypothetical protein, conserveda
Hs-CTC1 NP_079375.3 fasta36 LmxM.07.0802 42 382 0.06 Hypothetical protein, conserveda
Hs-CTC1 NP_079375.3 fasta36 LinJ.24.0600 43 351 0.17 Hypothetical protein, unknown functionb
Hs-CTC1 NP_079375.3 fasta36 LdBPK_240600.1 43 351 0.57 Hypothetical protein, unknown functionb
Mm-CTC1 NP_001268393.1 fasta36 LmjF.03.0180 41 201 0.63 Hypothetical protein, conserved
Mm-CTC1 NP_001268393.1 fasta36 LmxM.24.0960 42 515 0.89 Hypothetical protein, conserved
Sp-Stn1 CAL44730.1 fasta36 LbrM.32.0030 50 114 0.09 Hypothetical protein, conserved
On-TBP_A 1OTC (Chain A) fasta36 Tb427.10.11510 50 228 0.73 Hypothetical protein, conservedd
On-TBP_A 1OTC (Chain A) fasta36 Tb927.10.11510 50 228 0.86 Hypothetical protein, conservedd
Mm-Pot1 AAH16121.1 phmmer Tb427.08.1580 54 72 0.44 Hypothetical_protein,_conservede
Mm-Pot1 AAH16121.1 phmmer Tb927.8.1580 54 72 0.46 Hypothetical_protein, conservede
Mm-Ten1 CAM16382.1 phmmer LmjF.35.2590 52 72 0.092 Hypothetical_protein,_conserved
On-TBP_B 1OTC (Chain B) phmmer LdBPK_240840.1 53 88 0.3 Inositol polyphosphate phosphatase, putativec
On-TBP_B 1OTC (Chain B) phmmer LinJ.24.0840 53 88 0.3 Inositol polyphosphate phosphatase, putativec
On-TBP_B 1OTC (Chain B) phmmer Tb927.6.2870 66 57 0.67 Hypothetical_protein, conserved
Any – blastp No hits found – – – –
On-TBP_B 1OTC (Chain B) tblastn LtaP36 40 165 0.91 –
Mm-Pot1 AAH16121.1 tfastx36 LtaPseq60 46 217 1.8 –
Mm-Pot1 AAH16121.1 tfastx36 Tcruzi_3212 42 281 8.9 –
Hs-Pot1 AAH02923.1 tfastx36 Tcruzi_18093 45 257 7.3 –
Hs-CTC1 NP_079375.3 tfastx36 Tcruzi_14428 45 440 1.7 –
Mm-CTC1 NP_001268393.1 tfastx36 Tcruzi_6392 37 336 2.4 –
Mm-CTC1 NP_001268393.1 tfastx36 Tcruzi_950 45 328 5.2 –
Mm-CTC1 NP_001268393.1 tfastx36 LbrM.04 43 336 7.4 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_11348 43 93 1.6 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_23694 43 93 1.7 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_12467 43 93 1.7 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_105 44 104 4 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_205 45 121 5.6 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_14822 48 95 8.6 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_26059 46 86 8.7 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_11606 46 86 9.1 –
On-TBP_B 1OTC (Chain B) tfastx36 Tcruzi_1137 46 86 9.2 –
Sc-CDC13 AAA99990.1 Any No hits found – – – –
a,b,cOrthologous genes. d,eSame gene on different strains.
Hs, Homo sapiens; Lb, Leishmania braziliensis; Ld, Leishmania donovani; Lin, Leishmania infantum; Lmj, Leishmania major; Lmx, Leishmania mexicana; Lta, Leishmania tarentolae;
Mm, Mus musculus; On, Oxytricha nova; Sc, Saccharomyces cerevisiae; Sp, Schizosaccharomyces pombe; Tb, Trypanosoma brucei; Tcruzi, Trypanosoma cruzi.
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data show that linker 2 from yeast Rfa1 is still more ﬂexible than
linker 2 of hRPA70, but it is less ﬂexible than linker 2 of LaRPA-1.
The observation of the DNA-binding channel on DBD-C (Suppl.
Fig. 1B) and the ﬂexibility of linker 2 show that the yeast Rfa1
has structural features similar to both hRPA70 and LaRPA-1,
strongly suggesting that these differences appeared during
evolution.
In summary, this work shows that RPA-1 from L. amazonensis is
structurally distinct from other eukaryotic RPA-1 due to its relevant
differences, such as the absence of the RPA70N OBF domain, the
interaction with ssDNA (here, represented by telomeric DNA) only
via its N-terminal OBF1 domain, the structural and electrostatic
potential surface differences observed in OBF3 and the higher ﬂex-
ibility of the linkers between the three OBF domains. The absence of
DNA binding to OBF2 and OBF3 of LaRPA-1 contrasts the high afﬁn-
ity shown by hRPA70 for ssDNA (dissociation constant [Kd] of
0.05 nM) because in hRPA70, DNA binding involves the three
OBF domains, DBD-A, DBD-B and DBD-C [18]; therefore, the
absence suggests a reduced afﬁnity of LaRPA-1 for DNA. In fact,
the afﬁnity of LaRPA-1 for DNAmay be similar to that of the individ-
ual DBD-A (Kd of 2 lM, accordingly to [38]) due to the conserva-
tion of the primary and tertiary structures between the two
proteins (Figs. 2 and 4). These data are in agreement with previous
results that showed a smaller afﬁnity of LaRPA-1 for G-rich
telomeric strands compared with that of POT1 and CDC13 [14].The results presented here together with our previous results
[9,13,14,32] raise questions about the roles played by LaRPA-1 at
Leishmania telomeres, since budding and ﬁssion yeast RF-A are
present at the telomeres and are involved with regulation of telo-
merase activity and telomere maintenance [40,41]. In addition,
orthologs to the single-stranded telomere end-protection proteins
(TEP) have never been reported in trypanosomatids. The orthologs
include the conserved POT1 and the components of CST (CDC13,
STN1, TEN1) and the CST-like complex (CTC1, STN1, TEN1) that
were reported in yeast, fungi, plants and vertebrates, respectively,
and which were recognized as RPA-like proteins or telomeric RPAs
[6,42,43]. Although all of these proteins share structural homology
with RPA OBF domains, the sequence identity is limited, and in
contrast to RPA, most of them bind telomeric DNA with very high
afﬁnity (300 pM) [44]. To ﬁnd any of these protein homologues in
the TriTryp genome database (tritrypdb.org), we performed a thor-
ough and low stringent in silico search in the local ﬁles of both all
annotated proteins and whole genomes (downloaded from Trit-
rypDB v7.0) using ﬁve different algorithms (blastp, fasta36 and
phmmer, tblastn and tfastx36) (Table 1). The results presented in
Table 1 indicate the absence of homologues to any of these sin-
gle-stranded telomeric proteins, since the alignment hits appeared
to be spurious (high E-values) and were not reproducible by differ-
ent algorithms. It suggests that the protein machinery involved in
trypanosomatid telomere protection is most likely constituted by
other proteins, such as LaRPA-1.
R.S. Pavani et al. / FEBS Letters 588 (2014) 4740–4748 4747Here, it is important to note that in budding and ﬁssion yeast,
besides playing many roles in other DNA processing pathways,
RF-A acts at S phase associating with and directly facilitating telo-
merase activity at chromosome ends [45]. Additionally, hRPA can
bind telomeres outside of S phase to recruit DNA damage response
proteins via its RPA70N OBF domain, which triggers an ATR check-
point [29]. The absence of this domain in LaRPA-1 raises the possi-
bility that RPA may be not involved in a checkpoint response.
Recently, we showed that after the induction of DNA double-
stranded breaks, LaRPA-1 accumulated with LaRAD51 in the
nucleus in S phase, immunoprecipitated telomeres in vivo and
associated in a complex containing RAD51, suggesting that upon
damage, LaRPA-1 prevents the loss of single-stranded DNA and
assumes a capping function [32]. All these lines of evidence,
together with the results presented here, suggest that LaRPA-1
can be a good candidate as a Leishmania telomere end-binding
protein.
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